# Bradley S. Galer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bradley-s-galer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,826 |
| Field | Pain Mechanisms and Treatments |
| h-index | 57 |
| i10-index | 101 |
| Last Known Institution | Rapt Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5009823256 |
| ORCID iD | https://orcid.org/0000-0002-4735-3327 |
| Works | 169 |

## Researcher papers

- [Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/fenfluramine-hydrochloride-for-the-treatment-of-seizures-in-dravet-syndrome-a/)
- [Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens](https://scholariq.org/papers/fenfluramine-for-treatment-resistant-seizures-in-patients-with-dravet-syndrome/)
- [Safety and Tolerability of the Lidocaine Patch 5%, a Targeted Peripheral Analgesic: A Review of the Literature](https://scholariq.org/papers/safety-and-tolerability-of-the-lidocaine-patch-5-a-targeted-peripheral-analgesic/)

## Researcher topics

- [Pain Mechanisms and Treatments](https://scholariq.org/topics/pain-mechanisms-and-treatments/)
- [Musculoskeletal pain and rehabilitation](https://scholariq.org/topics/musculoskeletal-pain-and-rehabilitation/)
- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)
- [Pain Management and Treatment](https://scholariq.org/topics/pain-management-and-treatment/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)

## Researcher university

- [Rapt Therapeutics (United States)](https://scholariq.org/institutions/rapt-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
